A recent post published by Clay Siegall on his blog highlighted a man who was able to use the power of thoughts to control his limb through the use of a robotic machine. The article touches on the technological innovations and advancements currently witnessed in the modern world of science. This technology will be a tremendous contribution to the medical field.
Another interesting article is about the March madness that has hit the school. The article talks about how March mammal madness has had an impact on most students. They tend to bet on which animal will win a fight. March mammal madness was created by Arizona State University biologist Katie Hinde. Katie sees this as an opportunity of having fun while educating students at the same time.
Clay Siegall is the co-founder and President of Seattle Genetics. He also serves as the CEO and is a member of the Board of Directors. He co-founded this company in 1998 and had remained on the front line in the battle against cancer. Seattle Genetics has significantly contributed to the fight against cancer by developing clinical products. The company is responsible for antibody-drug conjugate (ADC), which is an antibody that has helped many patients.
In 2011, Siegall guided his company to raise over $1.2 billion through IPO and private funding. Through his leadership, the company has managed to stay on course in a fight against cancer. Investors’ confidence in Sieagall’s company is a clear indication of the better things to come.
Before founding Seattle Genetics, Siegall worked with the National Institutes of Health, and before that, he was with Bristol-Myers Squibb Pharmaceutical Research Institute.
As the CEO of Seattle Genetics, Siegall is responsible for guiding the company into greater heights. As a trusted figure, he is allocated the responsibilities of fundraising and ensuring investors have confidence in the company.
His leadership skills were witnessed when the company raised funds to run their research. He was awarded the University of Maryland Alumnus of the Year. Due to his vast knowledge, he serves on Board of Director of many companies, including Alder BioPharmaceuticals and Fred Hutchinson Cancer Research Business Alliance.